Literature DB >> 9537439

Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts.

T Martelius1, L Krogerus, K Höckerstedt, C Bruggeman, I Lautenschlager.   

Abstract

It has been suggested that cytomegalovirus (CMV) infection is involved in allograft rejection. In liver transplantation, it has been suggested that CMV is associated with the development of vanishing bile duct syndrome (VBDS), and persistent CMV has been found in liver grafts that develop chronic rejection. In this experimental study, the effect of rat CMV (RCMV) infection on intragraft changes was investigated in a rat model of acute liver allograft rejection. Liver transplantations were performed in a rat strain combination of PVG (RT1c) --> BN (RT1n). No immunosuppression was given. One group of animals was infected with RCMV Maastricht Strain (10(5) plaque-forming units, intraperitoneally), and another group was left uninfected. The grafts were examined histologically after the rats were killed on postoperative days 7 through 9 at the early phase and days 20 through 30 at the late phase of rejection. Immunohistochemical studies were performed to demonstrate the immunological activation markers major histocompatibility complex class II and interleukin 2 receptors, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and their ligands. RCMV infection was demonstrated from the grafts by culture and direct antigen detection. In liver allografts undergoing acute rejection, CMV significantly increased portal inflammation and caused more severe bile duct damage than in the uninfected grafts. CMV was also linked to the induction of VCAM-1 in the endothelial cells. The ongoing infection was found to vary over time in the different structures of the liver grafts, including the vascular endothelium and bile ducts. Our results support an association between CMV infection and the immunological mechanisms of rejection, as well as the role of CMV in the development of bile duct damage in liver allografts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9537439     DOI: 10.1002/hep.510270415

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  16 in total

1.  Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.

Authors:  T Martelius; M Salmi; H Wu; C Bruggeman; K Höckerstedt; S Jalkanen; I Lautenschlager
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

Review 3.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

4.  Hepatobiliary Quiz Answers-17 (2016).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-05-04

Review 5.  Infections after orthotopic liver transplantation.

Authors:  Mark Pedersen; Anil Seetharam
Journal:  J Clin Exp Hepatol       Date:  2014-07-24

6.  Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipients.

Authors:  S L Orloff; Y-K Hwee; C Kreklywich; T F Andoh; E Hart; P A Smith; I Messaoudi; D N Streblow
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

7.  Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Authors:  Ana Paula Oppenheimer; Christopher Koh; Mary McLaughlin; John C Williamson; Thomas D Norton; Jennifer Laudadio; Theo Heller; David E Kleiner; Kevin P High; Caryn G Morse
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

9.  Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis.

Authors:  Arun P Palanisamy; D J Taber; A G Sutter; S N Nadig; J E Dowden; J W McGillicuddy; P K Baliga; K D Chavin
Journal:  J Gastrointest Surg       Date:  2014-10-16       Impact factor: 3.452

Review 10.  Cytomegalovirus and chronic allograft rejection in liver transplantation.

Authors:  Liang-Hui Gao; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.